These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
105 related articles for article (PubMed ID: 30987507)
1. Targeted pharmacokinetics of polymeric micelles modified with glycyrrhetinic acid and hydrazone bond in H22 tumor-bearing mice. Zheng Y; Shi S; Liu Y; Zhao Y; Sun Y J Biomater Appl; 2019 Jul; 34(1):141-151. PubMed ID: 30987507 [No Abstract] [Full Text] [Related]
2. Glycyrrhetinic Acid-Mediated Polymeric Drug Delivery Targeting the Acidic Microenvironment of Hepatocellular Carcinoma. Zhang J; Zhang M; Ji J; Fang X; Pan X; Wang Y; Wu C; Chen M Pharm Res; 2015 Oct; 32(10):3376-90. PubMed ID: 26148773 [TBL] [Abstract][Full Text] [Related]
3. Glycyrrhetinic acid-decorated and reduction-sensitive micelles to enhance the bioavailability and anti-hepatocellular carcinoma efficacy of tanshinone IIA. Chen F; Zhang J; He Y; Fang X; Wang Y; Chen M Biomater Sci; 2016 Jan; 4(1):167-82. PubMed ID: 26484363 [TBL] [Abstract][Full Text] [Related]
4. Glycyrrhetinic acid-modified poly(ethylene glycol)-b-poly(gamma-benzyl l-glutamate) micelles for liver targeting therapy. Huang W; Wang W; Wang P; Tian Q; Zhang C; Wang C; Yuan Z; Liu M; Wan H; Tang H Acta Biomater; 2010 Oct; 6(10):3927-35. PubMed ID: 20438873 [TBL] [Abstract][Full Text] [Related]
5. Acid-sensitive polymeric vector targeting to hepatocarcinoma cells via glycyrrhetinic acid receptor-mediated endocytosis. Yan T; Cheng J; Liu Z; Cheng F; Wei X; Huang Y; He J Mater Sci Eng C Mater Biol Appl; 2018 Jun; 87():32-40. PubMed ID: 29549947 [TBL] [Abstract][Full Text] [Related]
6. Dehydroascorbic Acid and pGPMA Dual Modified pH-Sensitive Polymeric Micelles for Target Treatment of Liver Cancer. Ma H; Jiang C J Pharm Sci; 2018 Feb; 107(2):595-603. PubMed ID: 29024701 [TBL] [Abstract][Full Text] [Related]
7. Preparation and evaluation of liver-targeting micelles loaded with oxaliplatin. Yan G; Chen Q; Xu L; Wei H; Ma C; Sun Y Artif Cells Nanomed Biotechnol; 2016; 44(2):491-6. PubMed ID: 25287740 [TBL] [Abstract][Full Text] [Related]
8. Glycyrrhetinic acid-conjugated polymeric prodrug micelles co-delivered with doxorubicin as combination therapy treatment for liver cancer. Yang T; Lan Y; Cao M; Ma X; Cao A; Sun Y; Yang J; Li L; Liu Y Colloids Surf B Biointerfaces; 2019 Mar; 175():106-115. PubMed ID: 30529816 [TBL] [Abstract][Full Text] [Related]
12. A pH-Responsive Glycyrrhetinic-Acid-Modified Small-Molecule Conjugate for NIR Imaging of Hepatocellular Carcinoma (HCC). Singh H; Lim JY; Sharma A; Yoon DW; Kim JH; Yang Z; Qu J; Kim J; Lee SG; Kim JS Chembiochem; 2019 Feb; 20(4):614-620. PubMed ID: 30496637 [TBL] [Abstract][Full Text] [Related]
13. Amphiphilic multi-arm-block copolymer conjugated with doxorubicin via pH-sensitive hydrazone bond for tumor-targeted drug delivery. Prabaharan M; Grailer JJ; Pilla S; Steeber DA; Gong S Biomaterials; 2009 Oct; 30(29):5757-66. PubMed ID: 19643472 [TBL] [Abstract][Full Text] [Related]
14. Glycyrrhetinic acid-modified chitosan/poly(ethylene glycol) nanoparticles for liver-targeted delivery. Tian Q; Zhang CN; Wang XH; Wang W; Huang W; Cha RT; Wang CH; Yuan Z; Liu M; Wan HY; Tang H Biomaterials; 2010 Jun; 31(17):4748-56. PubMed ID: 20303163 [TBL] [Abstract][Full Text] [Related]
15. An efficient PEGylated liposomal nanocarrier containing cell-penetrating peptide and pH-sensitive hydrazone bond for enhancing tumor-targeted drug delivery. Ding Y; Sun D; Wang GL; Yang HG; Xu HF; Chen JH; Xie Y; Wang ZQ Int J Nanomedicine; 2015; 10():6199-214. PubMed ID: 26491292 [TBL] [Abstract][Full Text] [Related]
16. Doxorubicin-loaded glycyrrhetinic acid modified recombinant human serum albumin nanoparticles for targeting liver tumor chemotherapy. Qi WW; Yu HY; Guo H; Lou J; Wang ZM; Liu P; Sapin-Minet A; Maincent P; Hong XC; Hu XM; Xiao YL Mol Pharm; 2015 Mar; 12(3):675-83. PubMed ID: 25584860 [TBL] [Abstract][Full Text] [Related]
17. Cleavable Multifunctional Targeting Mixed Micelles with Sequential pH-Triggered TAT Peptide Activation for Improved Antihepatocellular Carcinoma Efficacy. Zhang J; Zheng Y; Xie X; Wang L; Su Z; Wang Y; Leong KW; Chen M Mol Pharm; 2017 Nov; 14(11):3644-3659. PubMed ID: 28994600 [TBL] [Abstract][Full Text] [Related]
18. Hybrid polypeptide micelles loading indocyanine green for tumor imaging and photothermal effect study. Wu L; Fang S; Shi S; Deng J; Liu B; Cai L Biomacromolecules; 2013 Sep; 14(9):3027-33. PubMed ID: 23941524 [TBL] [Abstract][Full Text] [Related]
19. In situ diselenide-crosslinked polymeric micelles for ROS-mediated anticancer drug delivery. Deepagan VG; Kwon S; You DG; Nguyen VQ; Um W; Ko H; Lee H; Jo DG; Kang YM; Park JH Biomaterials; 2016 Oct; 103():56-66. PubMed ID: 27372421 [TBL] [Abstract][Full Text] [Related]
20. Tumor cells-specific targeting delivery achieved by A54 peptide functionalized polymeric micelles. Du YZ; Cai LL; Liu P; You J; Yuan H; Hu FQ Biomaterials; 2012 Dec; 33(34):8858-67. PubMed ID: 22959183 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]